Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party

Federica Sora', Aleksandar Radujkovic, Sascha Dietrich, Henric-Jan Blok, Arnon Nagler, Francis Ayuk, Jürgen Finke, Johanna Tischer, Jiri Mayer, Yener Koc, Jakob Passweg, Jenny L. Byrne, Pavel Jindra, Joan Hendrik Veelken, Gerard Socié, Johan Maertens, Nicolaas Schaap, Michael Stadler, Maija Itälä-Remes, Eleni TholouliMutlu Arat, Vanderson Rocha, Per Ljungman, Ibrahim Yakoub-Agha, Nicolaus Kröger, Yves Chalandon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The prognosis of patients with blast crisis (BC) chronic myeloid leukemia (CML) is still dismal. Allogeneic stem cell transplantation (alloSCT) represents the only curative treatment option, but data on transplant outcomes are scarce. We therefore conducted a retrospective, registry based study of adult patients allografted for BC CML focusing on patients with active disease at transplant and pre-transplant prognostic factors. A total of 170 patients allografted for BC CML after tyrosine kinase inhibitor pre-treatment between 2004 and 2016 were analyzed. Prior to transplant, 95 patients were in remission, whereas 75 patients had active BC. In multivariable analysis of the entire cohort, active BC at transplant was the strongest factor associated with decreased overall survival (OS, HR 1.87, P=0.010) and shorter leukemia-free survival (LFS, HR 1.69, P=0.017). For patients with BC in remission at transplant, advanced age (≥45 years), lower performance status (≤80%), longer interval from diagnosis BC to transplant (>12 months), myeloablative conditioning, and unrelated donor (UD) transplant were risk factors for inferior survival. In patients with active BC, only UD transplant was significantly associated with prolonged LFS and trended towards improved OS. In summary, survival of patients allografted for BC CML was strongly dependent on the pre-transplant remission status. In patients with remission of BC, conventional prognostic factors remained the major determinants of outcome, whereas in those with active BC at transplant, UD transplantation was associated with prolonged LFS in our study.
Original languageEnglish
Pages (from-to)30412-30414
Number of pages3
JournalBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Volume2019
DOIs
Publication statusPublished - 2019

Keywords

  • allogeneic transplantation

Fingerprint

Dive into the research topics of 'Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party'. Together they form a unique fingerprint.

Cite this